Literature DB >> 2174097

Identification of ATP diphosphohydrolase activity in human term placenta using a novel assay for AMP.

T Papamarcaki1, O Tsolas.   

Abstract

Human term placenta contains an ATP diphosphohydrolase activity which hydrolyses ATP to ADP and inorganic phosphate and ADP to AMP and a second mole of inorganic phosphate. The activity has a pH optimum between 8.0 and 8.5. Magnesium or calcium ions are required for maximum activity. Other nucleoside phosphates, p-nitrophenyl phosphate or sodium pyrophosphate, are not hydrolysed. The activity is not due to ATPases, or to myokinase, as determined by the use of inhibitors. NaF and NaN3 were found to inhibit strongly the activity thus identifying it as an ATP diphosphohydrolase. A sensitive enzymatic assay for measurement of AMP, one of the products of the reaction, was established, based on the strong inhibition of muscle fructose 1,6-biphosphatase by AMP. The range of the assay was 0.05-0.8 microM AMP. ATP diphosphohydrolase was found to have a rate of AMP production from ADP twice the rate from ATP. Under the same conditions, the assay for Pi release, on the other hand, gave velocities similar to each other for the two substrates. The activity appears to be identical to the ADP-hydrolysing activity in placenta reported by others.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2174097     DOI: 10.1007/BF00231696

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  28 in total

1.  Aggregation of blood platelets by adenosine diphosphate and its reversal.

Authors:  G V BORN
Journal:  Nature       Date:  1962-06-09       Impact factor: 49.962

2.  Separation of adenosine phosphates by paper chromotography and the equilibrium constant of the myokinase system.

Authors:  L V EGGLESTON; R HEMS
Journal:  Biochem J       Date:  1952-09       Impact factor: 3.857

3.  Isolation of ahighly active fructose diphosphatase from rabit muscle: its subunit structure and activation by monovalent cations.

Authors:  W J Black; A Van Tol; J Fernando; B L Horecker
Journal:  Arch Biochem Biophys       Date:  1972-08       Impact factor: 4.013

4.  P 1 ,P 5 -Di(adenosine-5')pentaphosphate, a potent multisubstrate inhibitor of adenylate kinase.

Authors:  G E Lienhard; I I Secemski
Journal:  J Biol Chem       Date:  1973-02-10       Impact factor: 5.157

5.  Inhibition of platelet aggregation by placental extracts.

Authors:  R A Hutton; P Dandona; F P Chow; I L Craft
Journal:  Thromb Res       Date:  1980 Feb 1-15       Impact factor: 3.944

6.  On the mechanism of inhibition of intestinal alkaline phosphatase by L-phenylalanine. I. Kinetic studies.

Authors:  N K Ghosh; W H Fishman
Journal:  J Biol Chem       Date:  1966-06-10       Impact factor: 5.157

7.  Salivary apyrase of Rhodnius prolixus. Kinetics and purification.

Authors:  J J Sarkis; J A Guimarães; J M Ribeiro
Journal:  Biochem J       Date:  1986-02-01       Impact factor: 3.857

8.  Demonstration of a novel ecto-enzyme on human erythrocytes, capable of degrading ADP and of inhibiting ADP-induced platelet aggregation.

Authors:  J Lüthje; A Schomburg; A Ogilvie
Journal:  Eur J Biochem       Date:  1988-08-01

9.  Human placental 5'-nucleotidase: purification and properties.

Authors:  M H Maguire; T P Krishnakantha; D M Aronson
Journal:  Placenta       Date:  1984 Jan-Feb       Impact factor: 3.481

10.  The common occurrence of ATP diphosphohydrolase in mammalian plasma membranes.

Authors:  A F Knowles; R E Isler; J F Reece
Journal:  Biochim Biophys Acta       Date:  1983-05-26
View more
  2 in total

Review 1.  Purinergic signalling in the reproductive system in health and disease.

Authors:  Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2013-11-23       Impact factor: 3.765

2.  Purification of pancreas type-I ATP diphosphohydrolase and identification by affinity labelling with the 5'-p-fluorosulphonylbenzoyladenosine ATP analogue.

Authors:  J Sévigny; Y P Côté; A R Beaudoin
Journal:  Biochem J       Date:  1995-12-01       Impact factor: 3.857

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.